Compare RCKT & ZKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RCKT | ZKH |
|---|---|---|
| Founded | 1999 | 1998 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.2M | 465.1M |
| IPO Year | 2014 | 2022 |
| Metric | RCKT | ZKH |
|---|---|---|
| Price | $2.18 | $1.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 3 |
| Target Price | ★ $8.58 | $4.29 |
| AVG Volume (30 Days) | ★ 2.1M | 137.6K |
| Earning Date | 11-05-2026 | 11-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.37 | N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $10.56 |
| Revenue Next Year | $915.60 | $11.48 |
| P/E Ratio | $3.58 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.18 | $1.85 |
| 52 Week High | $5.45 | $3.90 |
| Indicator | RCKT | ZKH |
|---|---|---|
| Relative Strength Index (RSI) | 29.92 | 15.95 |
| Support Level | N/A | N/A |
| Resistance Level | $3.70 | $3.02 |
| Average True Range (ATR) | 0.16 | 0.15 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 5.00 | 1.83 |
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. Majority of the revenues are derived from the PRC.